Shopping Cart
- Remove All
- Your shopping cart is currently empty
Mapracorat is a novel, non-steroidal, selective agonist of the glucocorticoid receptor (GR).
Description | Mapracorat is a novel, non-steroidal, selective agonist of the glucocorticoid receptor (GR). |
In vitro | Mapracorat concentration-dependently inhibited TNFα secretion from activated canine PBMC (IC50: approximately 0.2 nM). |
In vivo | Intradermal injection of compound 48/80 (50 μg in 50 μL saline) induced a pronounced wheal and flare reaction within 60 minutes. Compared to vehicle (acetone)-treated areas, topical pre-treatment with mapracorat (0.1%) significantly reduced these wheal and flare responses. |
Alias | ZK-245186, BOL-303242X |
Molecular Weight | 462.48 |
Formula | C25H26F4N2O2 |
Cas No. | 887375-26-0 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 33.6 mg/mL (72.65 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.